This review aims to synthesize current insights into how CFTR modulators influence lung immunology within the context of a longer-living CF population, addressing emerging systemic health concerns and highlighting future directions for personalized, multidisciplinary management. The gene discussed is CFTR; the disease is cystic fibrosis.